Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
indiana blog main
life sciences
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
seattle blog main
5
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana top stories
national
national top stories
new york top stories
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
cancer
clinical trials
deals
medicare
merck
novartis
pfizer
venture capital
biogen
diabetes
diagnostics
fda
What
patients
5
×
bio
drug
roundup
market
acquisitions
advantages
albert
bar
becker
beta
biggest
billions
bionics
blood
bourla
brings
cancer
ceo
closed
company
crispr
developing
device
diabetes
dollars
driven
eaton
eisai
expect
fda
flags
future
gamble
gene
heads
healthcare
higher
impact
imports
Language
unset
unknown
Current search:
patients
×
biotech
×
" seattle blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests